Pipeline
Pipeline
Target ID
Indication
Development Stage
Co-Developer
Estimated
L/O Stage
YD312
c-Kit
Ophthalmology
(DME, DR, AMD)
Phase 2a
-
In Progress
YDC101
c-Kit
Ophthalmology. Oncology
Lead Optimization
SapiensBio
Candidate
YDC103
Αβ, Tau
Alzheimer’s Disease
Lead Optimization
SapiensBio
Candidate
YDC104
Confidential
Alzheimer’s Disease
Hit
ADDI at
Cambridge U. &
SapiensBio
Candidate
YDC105
Confidential
Fibrosis
Lead Optimization to Candidate
SapiensBio
Pre-Clinical
YDB102
Multigene-
Expression
Oncology
Hit
(POC in in-vivo animal model)
-
After POC
In Vivo Test
YDB201
Multi-Targets
Ophthalmology, Oncology
Hit
-
After POC
In Vivo Test
YDC103 Alzheimer's Disease
๋ฒ์ธ๋ช : ใ์์ด๋์๋ช ๊ณผํ ๋ํ์ : ์ด์ง์ฐ
์ฃผ์ : 13207 ๊ฒฝ๊ธฐ๋ ์ฑ๋จ์ ์ค์๊ตฌ ์ฌ๊ธฐ๋ง๊ณจ๋ก 148 (์๋์๋) ์ค์์ด๋ ธํ ํฌ 909ํธ
๋ณธ ์ฌ์ดํธ์ ์ฝํ
์ธ ๋ ์ ์๊ถ๋ฒ์ ๋ณดํธ๋ฅผ ๋ฐ๋๋ฐ, ๋ฌด๋จ ์ ์ฌ, ๋ณต์ฌ, ๋ฐฐํฌ ๋ฑ์ ๊ธํฉ๋๋ค.
Copyright โ 2016-2024 YD Global Life Science Co. Ltd. All Rights Reserved.